![](https://tracker.live.rns-distribution.com/track.live-rns/4984690_75d1671758db0ed18eba2dbba83793b2.png)
RNS
28 November 2023
Thruvision Group plc
("Thruvision" or the "Company")
Blocklisting update
Thruvision (AIM:THRU, "Thruvision" or the "Group"), the leading provider of walk-through security technology, today announces an update to its blocklisting application.
Name of Company: Thruvision Group plc
Name of Scheme: Thruvision Group plc Sharesave Scheme
Balance of Ordinary 1p shares under the 114,129
Scheme at 7 June 2023:
Number of Ordinary 1p shares issued 45,878
under the Scheme during the period:
Number of Ordinary 1p shares cancelled Nil
under the scheme during the period:
Balance of Ordinary 1p shares under the 68,251
Scheme at 28 November 2023:
At 28 November 2023 the total number of Ordinary Shares in issue with voting rights is 161,015,138.
No Ordinary Shares are held in treasury.
The above figure of 161,015,138 Ordinary Shares in the Company carrying voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.
For further information please contact:
Thruvision Group plc +44 (0)1235 425400
Victoria Balchin, Chief Financial Officer
Investec Investment Banking (NOMAD & Broker) +44 (0)20 7597 5970
Patrick Robb / James Rudd / Sebastian Lawrence
Meare Consulting +44 (0)79 9085 8548
Adrian Duffield
About Thruvision (www.thruvision.com)
Thruvision is the leading developer, manufacturer and supplier of walk-through security technology. Its technology is deployed in more than 20 countries around the world by government and commercial organisationsin a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using an advanced AI-based detection algorithm. The Group's offices are near Oxford and Washington DC.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.